Citations
314 |
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell
- DL, Timms, et al.
- 1998
(Show Context)
Citation Context ...is, inflammation, and calcium deposition (28). Additionally, its primary role may be in bone, where OPG is secreted by osteoblasts to inhibit differentiation and maturation of neighboring osteoclasts =-=(10,29,30)-=-. Higher levels of OPG probably indicate a compensatory increase of OPG locally in the vascular wall to counteract vascular calcium deposition or result from the transition of vascular smooth muscle c... |
109 |
Multiple imputation of missing values: Update of ICE.
- Royston
- 2005
(Show Context)
Citation Context ...variables or a Pearson’s chisquared test for categorical variables. Multiple imputation by chained equations was used to impute missing covariates (five cycles) before multivariable models were built =-=(25)-=-. The following covariates were imputed using all other covariates as predictors: history of cardiovascular disease (n=2; ,1%), history of diabetes (n=1; ,1%), body mass index (n=33; 5%), index of coe... |
86 | Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int - Zimmermann, Herrlinger - 1999 |
60 |
Clinical implication of the osteoprotegerin/ RANKL/RANK system for bone ans vascular disease.
- LC, Schoppet
- 2000
(Show Context)
Citation Context ...ct measures of calcification in this study to corroborate this. In fact, the circulating factorsmeasured in this study probably have pleiotropic effects, including roles in apoptosis and inflammation =-=(53)-=-, that could account for the observed associations. Furthermore, we cannot determine whether these factors play a causal role in the development of disease or are markers of the underlying pathophysio... |
54 |
Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
- CM, Bae, et al.
(Show Context)
Citation Context ...hosphate (11,14). OPG, OPN, and BMP-7 are produced by a variety of cell types, including endothelial and vascular smooth muscle cells, with increased expression in the setting of active calcification =-=(12,14,15)-=-. Numerous clinical studies have demonstrated associations between these biomarkers and measures of vascular calcification and stiffness (16–22). In this study, we evaluated the association between se... |
45 |
Bone morphogenetic proteins in vascular calcification. Circ Res.
- KA, Mathew, et al.
- 2005
(Show Context)
Citation Context ...hosphate (11,14). OPG, OPN, and BMP-7 are produced by a variety of cell types, including endothelial and vascular smooth muscle cells, with increased expression in the setting of active calcification =-=(12,14,15)-=-. Numerous clinical studies have demonstrated associations between these biomarkers and measures of vascular calcification and stiffness (16–22). In this study, we evaluated the association between se... |
45 | Osteopontin: a versatile regulator of inflammation and biomineralization,”Matrix - Giachelli, Steitz - 2000 |
39 |
CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: e10–e17
- Jono, MD, et al.
- 2000
(Show Context)
Citation Context ...ves are each associated with higher mortality in patients with ESRD (4). They may be initiated by the uremic milieu, as well as comorbid factors, such as diabetes, inflammation, and hyperphosphatemia =-=(5,6)-=-. Animal models have identified osteoprotegerin (OPG), osteopontin (OPN), bone morphogenic protein-7 (BMP7), and fetuin-A as factors that may regulate calcification in the vasculature (7–13). Fetuin-A... |
38 |
Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
- WG, Goldin, et al.
(Show Context)
Citation Context ... contribute to excess cardiovascular mortality may identify promising therapeutic targets in ESRD. Decades of clinical observations have noted deposition of extraosseous calcium in patients with ESRD =-=(2,3)-=-. Medial calcification of large vessels, intimal calcification of coronary arteries, and calcification of the cardiac valves are each associated with higher mortality in patients with ESRD (4). They m... |
34 |
Slatopolosky E: Vascular calcification: The killer of patients with chronic kidney disease
- Mizobuchi, Towler
(Show Context)
Citation Context ... ESRD (2,3). Medial calcification of large vessels, intimal calcification of coronary arteries, and calcification of the cardiac valves are each associated with higher mortality in patients with ESRD =-=(4)-=-. They may be initiated by the uremic milieu, as well as comorbid factors, such as diabetes, inflammation, and hyperphosphatemia (5,6). Animal models have identified osteoprotegerin (OPG), osteopontin... |
30 |
Thadhani R, Jüppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
- OM, Mannstadt, et al.
(Show Context)
Citation Context ...evelopment of left ventricular hypertrophy (42). Additionally, questions still remain on racial differences in FGF23 and other mineral metabolites, which is beyond the scope of the current manuscript =-=(35)-=-. Although OPG, OPN, and BMP-7 are produced locally in the vascular wall, fetuin-A is produced in the liver. FetuinA concentrations are high in calcified vascular lesions, where it is deposited from t... |
29 |
Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008;19:213–6
- SM, NX
(Show Context)
Citation Context ...ves are each associated with higher mortality in patients with ESRD (4). They may be initiated by the uremic milieu, as well as comorbid factors, such as diabetes, inflammation, and hyperphosphatemia =-=(5,6)-=-. Animal models have identified osteoprotegerin (OPG), osteopontin (OPN), bone morphogenic protein-7 (BMP7), and fetuin-A as factors that may regulate calcification in the vasculature (7–13). Fetuin-A... |
26 | Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences. Nephrol Dial Transplant 24: 948–955 - Jean |
24 | Westenfeld R, Ketteler M, Floege J, Müller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification - Schäfer, Heiss, et al. |
23 |
I . Pathophysiological roles of osteoprotegerin [3
- Reid
(Show Context)
Citation Context ...ts (27); however, differences by diabetic status have not been previously reported. OPG is secreted directly from the vascular wall, where it modulates apoptosis, inflammation, and calcium deposition =-=(28)-=-. Additionally, its primary role may be in bone, where OPG is secreted by osteoblasts to inhibit differentiation and maturation of neighboring osteoclasts (10,29,30). Higher levels of OPG probably ind... |
20 |
LM: Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-a. Diabetologia 48: 561–568
- Olesen, Ledet, et al.
- 2005
(Show Context)
Citation Context ...ication biomarkers may be less informative. Additionally, circulating levels of these biomarkers may be influenced by glucose and insulin levels, which further limits their utility in this population =-=(32,33)-=-. Associations between OPG and mortality among patients without diabetes were independent of inflammation and FGF-23, which is noteworthy because each is an independent risk factor for mortality in pa... |
18 | Ketteler M, Shlipak MG, Whooley MA, Ix JH: The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study. Ann Intern Med 152: 640–648 - BD, LJ, et al. - 2010 |
16 |
Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP
- Morena, Terrier
(Show Context)
Citation Context ...g calcification inhibitor, fetuin-A, in patients with calcifying vascular disease. The observed association of higher OPG levels and mortality is consistent with previous reports in dialysis patients =-=(27)-=-; however, differences by diabetic status have not been previously reported. OPG is secreted directly from the vascular wall, where it modulates apoptosis, inflammation, and calcium deposition (28). A... |
16 |
Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23,” Circulation,
- Lim, Lu, et al.
- 2012
(Show Context)
Citation Context ...F-23 has been associated with vascular calcification in several studies (37– 39), but not consistently (40), and experimental studies do not support a direct role of FGF-23 in promoting calcification =-=(40,41)-=-. Prior associations between FGF-23 and calcification may be in part due to its correlation with phosphate and klotho deficiency. It is more likely that the role of FGF23 leading to higher mortality i... |
15 | Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA: Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 115: 2533–2539 - JH - 2007 |
14 | Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. - MR, RJ, et al. - 2005 |
13 | fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 67(6 - Stenvinkel, Wang, et al. |
11 |
Jumabay M, Matveyenko A, Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res
- KI
(Show Context)
Citation Context ...ication biomarkers may be less informative. Additionally, circulating levels of these biomarkers may be influenced by glucose and insulin levels, which further limits their utility in this population =-=(32,33)-=-. Associations between OPG and mortality among patients without diabetes were independent of inflammation and FGF-23, which is noteworthy because each is an independent risk factor for mortality in pa... |
11 |
Isakova T, Gutiérrez OM, Aguillon-Prada R
- Faul, AP, et al.
(Show Context)
Citation Context ...s correlation with phosphate and klotho deficiency. It is more likely that the role of FGF23 leading to higher mortality in dialysis patients is due to the development of left ventricular hypertrophy =-=(42)-=-. Additionally, questions still remain on racial differences in FGF23 and other mineral metabolites, which is beyond the scope of the current manuscript (35). Although OPG, OPN, and BMP-7 are produced... |
9 | Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD - Honda, AR |
8 |
Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the Unites States. National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://www.usrds. org/adr.aspx
- States
(Show Context)
Citation Context ...ation and is largely attributed to cardiovascular causes. Although survival has improved modestly over the past decade, the annual adjusted mortality rate of 185.8 per 1000 patient-years remains high =-=(1)-=-. Detailed investigations into novel uremia-related risk factors that contribute to excess cardiovascular mortality may identify promising therapeutic targets in ESRD. Decades of clinical observations... |
7 |
Comparing the predictive powers of survival models using Harrell’s C or
- Newson
- 2010
(Show Context)
Citation Context ...ntinuous linear predictor and fetuin-A as a piecewise linear spline. We calculated a C-statistic for each model in the validation cohort and tested for differences in C-statistic across nested models =-=(26)-=-. All analyses were performed using Stata software, special edition 11.0 (Stata Corp., College Station, Texas) and a twosided a value of 0.05. Results The majority of the study population was treated ... |
6 | Tung E, Karsenty G, Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047–1055 - MY, MD, et al. - 2002 |
6 | Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ - RC, Shah |
6 | CL, Daniels LB, Ix JH: The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: The Rancho Bernardo study - GA, KM, et al. |
5 |
Jaar B, Fink NE, Tracy RP, PoweNR, KlagMJ: Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition
- Liu, Coresh, et al.
(Show Context)
Citation Context ...rsus normal serum phosphate (.5.5 mg/dl versus #5.5 mg/dl) and the presence of inflammation (defined as serum albumin,3.6 g/dl, C-reactive protein$10 mg/L, or IL-6$3.09 pg/ml, as previously described =-=[24]-=-) using stratified models and interaction terms in model 1. Restricted cubic splines were fit to explore nonlinear relationships between levels of calcification biomarkers and all-cause mortality afte... |
5 |
Rocks BF, Rajkumar C, Holt SG. Poor agreement between commercial ELISAs for plasma fetuin-A: an effect of protein glycosylation? Clin Chim Acta
- ER, ML, et al.
(Show Context)
Citation Context ... of Nephrology g/L were associated with increasing mortality, which may account for apparently conflicting results. Alternatively, differences in assay performance may contribute to the heterogeneity =-=(52)-=-. Despite the independent associations that we observed between OPG, fetuin-A, and mortality, the inclusion of these biomarkers did not improve clinical risk prediction in this study, and our findings... |
4 | Coche E, Robert A, Floege J, Goffin E, Jadoul M, Devuyst O. Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clin J Am Soc Nephrol - Marechal, Schlieper, et al. |
4 | Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 25: 2679–2685 - NasrallahMM, SalemMM, et al. - 2010 |
3 | osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clin J Am Soc Nephrol 6 - JJ, MB, et al. |
3 | Jaussent I, Vernhet H, Gahide G, Klouche K, Bargnoux A-S, Delcourt C, Canaud B, Cristol J-P: A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. Nephrol Dial Transp - Morena, Dupuy - 2009 |
3 |
Boyle WJ: Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309–319
- SimonetWS, CR, et al.
- 1997
(Show Context)
Citation Context ...is, inflammation, and calcium deposition (28). Additionally, its primary role may be in bone, where OPG is secreted by osteoblasts to inhibit differentiation and maturation of neighboring osteoclasts =-=(10,29,30)-=-. Higher levels of OPG probably indicate a compensatory increase of OPG locally in the vascular wall to counteract vascular calcium deposition or result from the transition of vascular smooth muscle c... |
3 | der Sande FM, Boeschoten EW, Leunissen KML, Krediet RT, Dekker FW; Netherlands cooperative study on the adequacy of Dialysis (NECOSAD): Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 72 - MMH, Brandenburg, et al. |
3 | S-F, Li PK-T, Sanderson JE: Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular 10 - AY-M, Woo, et al. |
3 | cardiovascular disease in older adults: The cardiovascular health study. Diabetes Care 36: 1222–1228 - MK, TM, et al. |
2 |
Alfrey AC,HufferWE, Craswell PW, Anderson JT,Weil R 3rd: Arterial calcification and pathology in uremic patients undergoing dialysis
- LS
- 1979
(Show Context)
Citation Context ... contribute to excess cardiovascular mortality may identify promising therapeutic targets in ESRD. Decades of clinical observations have noted deposition of extraosseous calcium in patients with ESRD =-=(2,3)-=-. Medial calcification of large vessels, intimal calcification of coronary arteries, and calcification of the cardiac valves are each associated with higher mortality in patients with ESRD (4). They m... |
2 |
DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260–1268
- BucayN, CR, et al.
- 1998
(Show Context)
Citation Context ...is, inflammation, and calcium deposition (28). Additionally, its primary role may be in bone, where OPG is secreted by osteoblasts to inhibit differentiation and maturation of neighboring osteoclasts =-=(10,29,30)-=-. Higher levels of OPG probably indicate a compensatory increase of OPG locally in the vascular wall to counteract vascular calcium deposition or result from the transition of vascular smooth muscle c... |
2 |
Fetuin-A regulation of calcified matrix metabolism. Circ Res 108
- Jahnen-DechentW, SchäferC
(Show Context)
Citation Context ...nd fetuin-A as factors that may regulate calcification in the vasculature (7–13). Fetuin-A is secreted by hepatocytes into the circulation, where it forms soluble complexes with calcium and phosphate =-=(11,14)-=-. OPG, OPN, and BMP-7 are produced by a variety of cell types, including endothelial and vascular smooth muscle cells, with increased expression in the setting of active calcification (12,14,15). Nume... |
2 |
Westenfeld R, Jahnen-DechentW,ChenNX: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67
- SM, ReslerovaM, et al.
(Show Context)
Citation Context ...nd fetuin-A as factors that may regulate calcification in the vasculature (7–13). Fetuin-A is secreted by hepatocytes into the circulation, where it forms soluble complexes with calcium and phosphate =-=(11,14)-=-. OPG, OPN, and BMP-7 are produced by a variety of cell types, including endothelial and vascular smooth muscle cells, with increased expression in the setting of active calcification (12,14,15). Nume... |
2 | Cuppari L, Cendoroglo M, Draibe SA, Moyses RMA - DV, FC, et al. |
2 | Atalar E, Hazirolan T, Haznedaroglu İ, Akata D,OzerN, Aksoyek S,Ovunc K,Ozmen F: Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring - Aryan, Kepez |
2 |
AS; Medical Directors, Dialysis Clinic, Inc: Predicting 1 year mortality in an outpatient haemodialysis population: A comparison of comorbidity instruments. Nephrol Dial Transplant 19: 413–420
- DC, AA, et al.
- 2004
(Show Context)
Citation Context ...an Clemente, CA) were measured within 6 months of enrollment. Baseline comorbid conditions were abstracted from predialysis medical records, and the Index of Co-Existent Disease (ICED) was calculated =-=(23)-=-. Deaths were ascertained through March 31, 2009, by linkage with the US Renal Data System. Cause of death was ascertained through December 31, 2004, from the National Death Index, with chart review t... |
2 |
Hata T, Sasaki S: Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25: 1888–1895
- Hanada, Ando, et al.
- 2010
(Show Context)
Citation Context ...atients without diabetes than among patients with diabetes. Diabetes is a strong independent stimulus for vascular calcification and is associated with poor outcomes among patients receiving dialysis =-=(1,31)-=-. In our study population, cumulative survival was worse among those with than in those without diabetes. It is possible that among a population with a very high prevalence of vascular calcification a... |
2 | Lenglet A, Lemke HD, Choukroun G, Drueke T, Massy Z: FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.Osteoporos Int 23: 2017–2025 - Desjardins, Liabeuf, et al. |
2 | Hurot JM, Deleaval P, Chazot C: Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract 120: c132–c - Jean, Bresson, et al. - 2012 |
2 |
Cohort Study Investigators: Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83
- JJ, WL, et al.
(Show Context)
Citation Context ... is an independent risk factor for mortality in patients undergoing dialysis (34–36). In fact, FGF-23 has been associated with vascular calcification in several studies (37– 39), but not consistently =-=(40)-=-, and experimental studies do not support a direct role of FGF-23 in promoting calcification (40,41). Prior associations between FGF-23 and calcification may be in part due to its correlation with pho... |
2 |
AH, Böhm R,Metzger T,Wanner C, Jahnen-DechentW, Floege J: Association of low fetuin-A (AHSG) concentrations in serumwith cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361: 827–833
- Ketteler, Bongartz, et al.
- 2003
(Show Context)
Citation Context ...nd mortality, with loss of statistical significance. Fetuin-A is a negative acute phase reactant that is correlated with other inflammatory markers; therefore, these models may have been overadjusted =-=(46)-=-. It is plausible that inflammation and fetuin-A are factors in a shared pathophysiologic pathway, whereby chronic inflammation contributes to deficiency of fetuinA, promoting dystrophic calcification... |
2 | BeckGJ,GreeneT,WangX,Kusek JW, Collins AJ, Levey AS, Menon V: Fetuin-A is not associated with mortality in chronic kidney disease.Kidney Int72 - JH, ShlipakMG |
2 |
L,Giachelli CM:Osteopontin: amultifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27
- ScatenaM
(Show Context)
Citation Context ...c state. Many of the calcification biomarkers, such as OPN, are subject to phosphorylation and other post-translational modifications that affect their biologic activity and that we could not measure =-=(54)-=-, and single measurements may not adequately capture their variability over time. In addition, currently available serum assays do not distinguish between free serum fetuin-A and fetuin-A bound in fet... |
2 |
Rakugi H, Isaka Y: Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21: 1998–2007, 2010 Received: May 20, 2013 Accepted: November 11, 2013 Published online ahead of print. Publication date available at www. cjasn.
- Hamano, Matsui, et al.
(Show Context)
Citation Context ... over time. In addition, currently available serum assays do not distinguish between free serum fetuin-A and fetuin-A bound in fetuin-mineral complexes, which become more prevalent with advancing CKD =-=(55)-=-. Finally, although we found potentially important interactions between the presence of diabetes at baseline and some calcification biomarkers, we did not evaluate the impact of diabetic control on th... |